FDA approves selpercatinib for lung and thyroid RET tumorsMay 11, 2020Lung CancerHead & Neck/Thyroid Cancers
COVID-19 death rate was twice as high in cancer patients in NYC studyMay 5, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Excess cancer deaths predicted as care is disrupted by COVID-19May 1, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Antitumor treatment may increase risk of severe events in COVID-19 patientsMay 1, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLung CancerOncology
ASCO panel outlines cancer care challenges during COVID-19 pandemicApril 27, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Will coronavirus restrictions lead to more advanced cancers?April 23, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
European cancer centers restructure care in the era of COVID-19April 22, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Want to keep cancer patients and providers safe during the pandemic? Here’s howApril 20, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Cancer patients report delays in treatment because of COVID-19April 17, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Cancer care ‘transformed in space of a month’ because of pandemicApril 17, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
ASCO announces its own COVID-19 and cancer registryApril 13, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Cancer prevalence among COVID-19 patients may be higher than previously reportedApril 13, 2020Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersLung CancerMelanoma
Home-based chemo skyrockets at one U.S. centerApril 10, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Conducting cancer trials amid the COVID-19 pandemicApril 8, 2020MelanomaLymphoma & Plasma Cell DisordersLung CancerLeukemia, Myelodysplasia, TransplantationHead & Neck/Thyroid CancersGenitourinary CancerBreast Cancer
Advice from the front lines: How cancer centers can cope with COVID-19April 2, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
